已通过 Japp-Klingemann 反应从适当的 N-芳基-2-氯-3-氧代丁酰胺制备了氧代-N-芳基腙酰氯。标题化合物的结构已通过单晶 X 射线结构测定和 IR 光谱确定固态,并通过 IR、UV 和 1 H 和 13 C NMR 光谱确定在溶液中。结果表明腙酰氯部分采用(Z)-构型形式。在晶体中,氯官能团之间一般存在分子内氢键。
The present teachings relate to novel compounds of formula I:
wherein the constituent variables are as defined herein. Compounds of the present teachings can act as antagonists of the mammalian adhesion proteins known as selecting. Methods for treating or preventing selectin-mediated disorders are provided, which include administration of these compounds in a therapeutically effective amount.
Oxanilic acids, a new series of orally active antiallergic agents
作者:John H. Sellstedt、Charles J. Guinosso、Albert J. Begany、Stanley C. Bell、Marvin Rosenthale
DOI:10.1021/jm00243a014
日期:1975.9
antiallergic activity using the rat passive cutaneous anaphylaxis (PCA) test. Many of the oxanilic acid esters are activeorally, with the most active species having an aryl 2'-carbamoyl group and a 3'-methoxy group. Hydrolysis of the ester from the oxanilic ester moiety causes a loss of oral activity.
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
申请人:——
公开号:US20010034359A1
公开(公告)日:2001-10-25
The present invention is directed to compositions that inhibit the nonenzymatic glycation of albumin, as well as methods of using compounds that inhibit albumin glycation for the treatment of glycation-related pathologies.
本发明涉及抑制白蛋白非酶促糖基化的组合物,并使用抑制白蛋白糖基化的化合物治疗糖基化相关病理的方法。
Benzylamine derivative
申请人:Nagasawa Masaaki
公开号:US20060194841A1
公开(公告)日:2006-08-31
The invention provides a compound which exhibits satisfactory peroral absorbability and excellent antagonistic activity against NK-1 receptor or NK-2 receptor. The compound is a benzylamine derivative represented by formula (1) or a salt thereof.
Process for preparing substituted 4-alkyl-2(1H) quinazolinone-1-alkanoic acid derivatives
申请人:ORTHO PHARMACEUTICAL CORPORATION
公开号:EP0138492A2
公开(公告)日:1985-04-24
A process for preparing 4-alkyl-2(1H)quinazolinone-1-alkanoic acid derivatives is described. The 4-alkyl-2(1H)quinazolinones are useful as cardiovascular agents.